Perivascular Macrophages Mediate Microvasospasms After Experimental Subarachnoid Hemorrhage

Xiangjiang Lin1,2, Igor Khalin1,2, Biyan Nathanael Harapan1,3,2

  • 1Institute for Stroke and Dementia Research (ISD) (X.L., I.K., B.N.H., N.A.T., J.S., N.P.), Munich University Hospital, Germany.

Stroke
|June 16, 2023
PubMed
Abstract

Insights

Perivascular macrophages (PVMs) contribute to microvasospasms after subarachnoid hemorrhage (SAH). Depleting PVMs significantly reduced microvasospasms, suggesting a key role in SAH-induced vascular dysfunction.

Area of Science:

  • Neuroscience
  • Immunology
  • Vascular Biology

Background:

  • Subarachnoid hemorrhage (SAH) can cause reduced cerebral blood flow (CBF) due to cerebral artery spasms.
  • Inactivating perivascular macrophages (PVMs) improves outcomes in experimental SAH, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the role of PVMs in the formation of acute microvasospasms following experimental SAH.

Main Methods:

  • PVMs were depleted using clodronate liposomes in mice.
  • SAH was induced, and microvasospasms were quantified using in vivo 2-photon microscopy.
  • PVM depletion was confirmed via immunohistochemistry.

Main Results:

  • PVMs were located around arterioles and effectively depleted by clodronate.
  • SAH increased PVMs and caused microvasospasms in pial and penetrating arterioles.
  • PVM depletion significantly reduced the number of microvasospasms post-SAH.

Conclusions:

  • PVMs play a significant role in the development of microvasospasms after experimental SAH.
  • Targeting PVMs may be a therapeutic strategy for managing SAH-induced vascular complications.